Sunil Agarwal, President of R & D at Juno Therapeutics, Inc. (JUNO), sold 14,570 shares at $44.76 ($652K) on 2017-10-02, disclosed to the SEC on 2017-10-04.
Open-market sale of $652k JUNO by President of R & D. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $44.76 | 7,285 | $326K | 50.0% |
| 2 | $44.76 | 7,285 | $326K | 50.0% |
| Total | $44.76 avg | 14,570 | $652K | 100% |
| Filing → |
| RARE | SELL | 2016-06-21 | $35K | — | Filing → |
| RARE | SELL | 2016-05-26 | $43K | — | Filing → |
| RARE | SELL | 2016-04-21 | $46K | — | Filing → |